Product Details
SLA/LP is a cytosolic soluble liver antigen / liver pancreas antigen found to be specifically detected in approximately 20% of the patients with AIH. Target of anti-SLA/LP is an approximately 50 kDa UGA serine tRNA- associated protein complex, which functions in the pathway of selenoprotein synthesis in human cells.